CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

LTRNLantern Pharma Inc.

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $1.01 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$12.91M
CountryUSA
RECENT INSIDER TRADES
  • 2026-05-14 · KEYSER D JEFFREY (Director) · BUY
  • 2026-05-14 · Schalop Lee Troy (Director) · BUY
  • 2025-06-13 · Fletcher Aaron G.L. (10% Owner) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders42
Shares held3,322,169
Value$13.42M
Percent of shares outstanding25.99%
As of quarter end2026-06-30
RECENT NEWS
  • Lantern Pharma receives Taiwan approval for LP-300 trial expansion
  • Lantern Pharma closes $4 million stock offering
  • Lantern Pharma announces up to $8M registered direct offering
  • Lantern Pharma Inc. (LTRN) Discusses Open-Medicine AI Platform Roadmap, Business Model, and Value Proposition for Therapeutic Development
  • Lantern Pharma Inc. (LTRN) Discusses Open-Medicine AI Platform Roadmap, Business Model
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Lantern Pharma Inc. (LTRN) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit